Şunu aradınız:: tneħħitilhom (Maltaca - İngilizce)

tneħħitilhom il- milsa
placebo (n = 42)

studju 2 pazjenti li tneħħitilhom il-milsa
study 2 splenectomised patients

pazjenti aids- ks li tkun tneħħitilhom il- milsa:
aids-ks patients with splenectomy:

caelyx mhuwiex rakkomandat għal pazjenti li tneħħitilhom il-milsa.
caelyx is not recommended for patients whose spleen has been removed.

pazjenti b’aids-ks minħabba li tkun tneħħitilhom il-milsa
aids-related ks patients with splenectomy

caelyx mhuwiex rakkomandat għal pazjenti li tneħħitilhom il- milsa jew għat- tfal.
caelyx is not recommended for patients whose spleen has been removed or for children.

wara, tlieta minn dawk li wrew rispons parzjali tneħħitilhom il-marda permezz ta’operazzjoni.
three of the partial responders were subsequently rendered disease free by surgery.

studju minnhom sar fuq irġiel dijabetiċi u ieħor fuq irġiel li kienet tneħħitilhom il-glandola tal-prostata.
one of these studies was carried out in diabetic men and another in men who had had their prostate gland removed.

fuq livell internazzjonali hemm bosta prinċipji ta' gwida dwar kif għandhom jiġu ttrattati tfal li tneħħitilhom il-libertà tagħhom20.
at international level there are several guiding principles on how to deal with children who are deprived of their liberty20.

studju minnhom sar fi rġiel dijabetiċi u ieħor f' pazjenti li tkun saritilhom prostatektomija (tneħħitilhom il- prostata).
one study was carried out in diabetic men and another in post-prostatectomy patients (men who have had their prostate gland removed).

il-medjan tad-doża medja ta’ kull ġimgħa għall-pazjenti li tneħħitilhom il-milsa kienet 3 µg/kg u għall-pazjenti li ma tneħħitilhomx il-milsa kienet 2 µg/kg.
the median average weekly dose for splenectomised patients was 3 µg/kg and for non-splenectomised patients was 2 µg/kg.